Stock offering and NewConnect listing
In June 2017, we conducted a private placement of shares for Nestmedic S.A., from which the Company raised a total of more than PLN 8.4 million to continue research and development of the Pregnabit system and expand abroad. We also served as an Authorized Adviser on the NewConnect market.
Nestmedic S.A. is the manufacturer of the technologically innovative Pregnabit mobile telemedicine solution for remote examination of fetal well-being, i.e., cardiotocography (KTG). The company is a provider of a comprehensive offer encompassing its own medical product (teleKTG) and the service of remote analysis of KTG recordings by qualified medical personnel at the Medical Telemonitoring Center.
In June 2022, the company became the first manufacturer holding the MDR certificate in the Polish market. At the same time, Nestmedic has also distinguished itself globally – it is the first company in the world to obtain MDR certification (as a medical device) for a mobile KTG.
Service: Raising capital and investors
Client:
NESTMEDIC S.A.
Web address:
nestmedic.com/enTransaction type:
CAPITAL ACQUISITION, ADVISORY SERVICES
Investor
CAPITAL ONE ADVISERS IN NUMBERS
COMPLETED
TRANSACTIONS
82
TOTAL VALUE
OF TRANSACTIONS
2.65
BILLION ZLOTYS
COMPANIES TAKEN
PUBLIC
34
OUR
EXPERIENCE
24
YEARS
LICENSES AND PARTNERSHIPS
Pandea Global M&A
WSE Partner
for SME
Authorized NewConnect
Adviser 2007–2026
Authorized Catalyst
Adviser 2009–2026
Polish Private Equity
and Venture Capital Association